Arpita Kulkarni
Papers
1
Total Citations
13
H-Index
1
About
Arpita Kulkarni’s research bridges population genomics and precision public health, with a focus on identifying inherited cancer syndromes and familial hypercholesterolemia (FH) to enable early intervention. Her most-cited work, “Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon” (2023, 13 citations), exemplifies her commitment to translating genomic discoveries into actionable screening programs. By analyzing large-scale cohort data, Kulkarni demonstrated that systematic, community-based screening can uncover hidden genetic risks—such as BRCA1/2 and Lynch syndrome variants—alongside FH mutations, often missed in traditional clinical settings. This study not only highlighted the feasibility of integrating cancer and cardiovascular risk assessment but also provided a blueprint for state-level public health initiatives. Kulkarni’s contributions extend beyond her citation count; she has been instrumental in advocating for equitable access to genetic testing and counseling, particularly in underserved populations. Her work underscores the power of population screening to shift medicine from reactive treatment to proactive prevention, making her a rising voice in the field of genomic epidemiology.
Research Focus
Key Achievements
Top Papers
- 1